Table 2.
Baseline characteristics of individuals with and without liver fibrosis in NAFLD
| Non-liver fibrosis (n = 2352) |
liver fibrosis (n = 550) |
P value | |
|---|---|---|---|
| Age(years) | 48.89 ± 10.03 | 50.27 ± 11.00 | < 0.01 |
| Sex(male/Female) | 1831/521 | 451/99 | 0.03 |
| BMI (kg/m2) | 26.58 ± 2.61 | 28.55 ± 3.65 | < 0.01 |
| SBP (mmHg) | 129.88 ± 15.67 | 135.26 ± 16.92 | < 0.01 |
| DBP (mmHg) | 80.86 ± 10.83 | 83.25 ± 10.61 | < 0.01 |
| FBG (mmol/L) | 5.65 ± 1.23 | 6.18 ± 1.70 | < 0.01 |
| HbA1c (%) | 5.72 ± 0.78 | 6.03 ± 1.03 | < 0.01 |
| TC (mmol/L) | 5.41 ± 1.06 | 5.45 ± 1.06 | 0.37 |
| TG (mmol/L) | 2.12 ± 1.37 | 2.45 ± 1.81 | < 0.01 |
| LDL-C(mmol/L) | 3.43 ± 0.77 | 3.45 ± 0.76 | 0.63 |
| HDL-C(mmol/L) | 1.22 ± 0.25 | 1.18 ± 0.26 | < 0.01 |
| TyG index | 9.00 ± 0.56 | 9.20 ± 0.64 | < 0.01 |
| Uric acid (umol/l) | 372.61 ± 84.49 | 388.56 ± 82.01 | < 0.01 |
| ALT (U/L) | 29.58 ± 17.92 | 39.51 ± 25.61 | < 0.01 |
| AST (U/L) | 24.90 ± 10.41 | 30.47 ± 16.45 | < 0.01 |
| GGT (U/L) | 42.92 ± 31.63 | 52.70 ± 38.39 | < 0.01 |
Values are presented as mean ± standard deviation
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, TC total cholesterol, TG triacylglyceride, LDL-C high-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TyG triglyceride and glucose index, ALT alanine aminotransferase, AST aspartate transaminase, GGT gamma-glutamyl transpeptidase